|
|||||
A bioengineering lab developed a technique to attach larger quantities of cancer-fighting proteins to immune system cells that in lab mice reduced or eliminated tumors while avoiding harmful side effects. . . . → Read More: Nanoparticles Shown to Boost Anti-Cancer Immune Cells  One comment - (Comments are closed)  New products  biomedical, biotechnology, cancer, engineering, entrepreneurs, life sciences, materials science, nanotechnology, pharmaceuticals, physical sciences, preclinical, university 
A gene therapy technique that stops production of a targeted protein is shown in tests with monkeys to reduce levels of harmful cholesterol, but also expose potential risks associated with the technique. . . . → Read More: Gene Therapy Shown to Reduce Extreme High Cholesterol Comments are closed Joint ventures/collaborations, New products biomedical, biotechnology, genomics, heart disease, life sciences, patent, pharmaceuticals, preclinical, university 
An engineering team at Tufts University is developing a self-contained bandage with sensors that monitor the status of chronic wounds, and also dispenses medication as needed. . . . → Read More: Smart Bandage Monitors, Provides Drugs to Chronic Wounds Comments are closed New products biomedical, engineering, life sciences, materials science, medical device, nanotechnology, preclinical, semiconductors, software, university 
An bioengineering team created a process to formulate insulin, needed regularly by people with diabetes, as a liquid, to be taken in capsules rather than injections. . . . → Read More: Insulin Formulated as Liquid for Capsule Delivery Comments are closed New products biomedical, engineering, life sciences, pharmaceuticals, preclinical, university 
A company spun-off from a University at Buffalo biochemistry lab is the recipient of a small business grant to design a once-a-week drug for people with type 2 diabetes to control their blood sugar and weight. . . . → Read More: Univ. Spin-Off Developing Long-Lasting Diabetes Drug One comment - (Comments are closed) Finance, New products biomedical, biotechnology, chemistry, entrepreneurs, grant, life sciences, NIH, pharmaceuticals, physical sciences, preclinical, university 
A biotechnology company is receiving a grant from National Institute of Neurological Disorders and Stroke to advance its experimental treatments for amyotrophic lateral sclerosis, or ALS. . . . → Read More: $3.4M NIH Grant Funding New ALS Treatments Comments are closed Finance biomedical, biotechnology, entrepreneurs, equity, grant, investment, life sciences, NIH, pharmaceuticals, preclinical, university 
Gut microbes cultured in an artistic design (Nicola Fawcett, Wikimedia Commons) 18 June 2018. Researchers from a biotechnology company and a research institute are starting a joint project to find treatments for Parkinson’s disease targeting bacteria in the gut. Financial and intellectual property aspects of the partnership between Axial Biotherapeutics Inc. in Boston, and . . . → Read More: Biotech, Institute Partner on Gut Microbe Links to Parkinson’s Comments are closed Joint ventures/collaborations biomedical, biotechnology, life sciences, preclinical, university 
A combination of natural bacteria found in milk products and a synthetic variation of those microbes are shown in tests with lab mice to detect and prevent cholera infections. . . . → Read More: Natural, Engineered Microbes Shown to Control Cholera One comment - (Comments are closed) New products biomedical, biotechnology, engineering, entrepreneurs, life sciences, pharmaceuticals, preclinical, university 
A biomedical engineering team developed a dressing for diabetic skin wounds that harnesses the body’s own cell structuring proteins to regenerate new skin tissue for faster healing. . . . → Read More: Regenerative Dressing Designed for Diabetic Wounds Comments are closed New products biomedical, engineering, life sciences, medical device, patent, preclinical, university 
The National Heart, Lung, and Blood Institute and a biotechnology company are testing genome editing with electronically treated cells as a therapy for sickle cell disease. . . . → Read More: NIH, Biotech Partner on Electro-Aided Crispr for Sickle Cell One comment - (Comments are closed) Joint ventures/collaborations biomedical, biotechnology, genomics, life sciences, NIH, pharmaceuticals, preclinical |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
||||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
